Cibc World Markets Corp Repligen Corp Transaction History

Cibc World Markets Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$120.0 - $182.95 $82,200 - $125,320	685 Added 31.54%	2,857 $360,000
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $118,862 - $145,060	696 Added 47.15%	2,172 $399,000
Q4 2023 Feb 13, 2024	BUY	$114.17 - $185.35 $168,514 - $273,576	1,476 New	1,476 $265,000
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $907,143 - $1.21 Million	-5,469 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$180.37 - $226.26 $986,443 - $1.24 Million	5,469 New	5,469 $1.06 Million

481

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.36B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

Stay updated on Cibc World Markets Corp with notifications on news.